Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Outpatient dermatological chemotherapy].

U Reinhold1

  • 1Fachbereich Dermatologie, Allergologie, Dermatologische Onkologie, Medizinisches Zentrum Bonn Friedensplatz, Friedensplatz 16, 53111, Bonn, Germany. info@derma-bonn.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|November 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCT.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

High efficacy of red light photodynamic therapy with 10 % aminolevulinic acid gel irrespective of the extent of keratinocyte atypia in actinic keratosis - exploratory post-hoc analysis of three pivotal phase III trials.

Photodiagnosis and photodynamic therapy·2024
Same author

[Potassium hydroxide 5 % solution in actinic keratosis : A novel therapeutic approach in the lesion-directed treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2021
Same author

Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trial.

The British journal of dermatology·2018
Same author

A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.

The British journal of dermatology·2018

This review covers cytostatic chemotherapy for skin cancer, detailing drug uses, outpatient administration, and essential patient care guidelines for effective treatment.

Area of Science:

  • Dermatological Oncology
  • Pharmacology

Context:

  • Cytostatic chemotherapy is a cornerstone in managing dermatological cancers.
  • Outpatient administration is common, requiring specialized medical expertise and infrastructure.
  • Palliative care frequently involves cytostatic agents.

Purpose:

  • To review the spectrum of cytostatic drugs used in dermatological oncology.
  • To outline indications and applications for various skin cancers.
  • To highlight essential considerations for outpatient chemotherapy management.

Summary:

  • Discusses the role and application of cytostatic drugs in treating skin cancers.
  • Details the necessary medical knowledge and organizational structures for outpatient chemotherapy.
  • Reviews specific drugs, their indications, and management protocols.

Related Experiment Videos

  • Addresses critical aspects like nausea prevention, extravasation, and age-related patient factors.

    • Impact:

    • Provides a comprehensive overview for clinicians managing dermatological oncology patients.
    • Emphasizes the importance of specialized care and safety protocols in outpatient settings.
    • Aims to optimize the use of cytostatic chemotherapy for improved patient outcomes.